The deadline to respond to the 2025 Pressures Survey has been extended to Monday 10th March. We really want to hear from even more voices across the sector, as your views and first-hand experiences make all the difference in working towards delivering a stronger future for community pharmacy. The Pressures Survey continues to be a [...]
The post Pressures Survey extended: Every response matters appeared first on Community Pharmacy England.
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – March 2025 appeared first on Community Pharmacy England.
NHS England has announced that from late February and May 2025, the Electronic Prescription Service (EPS) will be fully extended to Detained Estate healthcare services in England. The staggered rollout will allow prescribers working in prisons to issue EPS ‘To Take Out’ (TTO) and urgent prescriptions electronically to community pharmacies, removing the need for the [...]
The post EPS rolls out for Detained Estate prescribers appeared first on Community Pharmacy England.
To enhance the security of the NHSmail system, the NHSmail team is updating its security arrangements. Users are being notified to replace their current security questions with an NHSmail Account Secret. You will receive reminders to assist you with this transition if you use NHSmail. What is the NHSmail Account Secret? The NHSmail Account Secret [...]
The post NHSmail security update: Transition to Account Secret appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Glucophage® SR 500 mg, 750mg and 1000mg prolonged-release tablets (Bruno Farmaceutici SpA, Italy) PL: Parallel Imports from the Italian market Date issued: 20 February 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Glucophage® SR 500mg, 750mg and 1000mg Prolonged-release Tablets [...]
The post MHRA Class 3 Medicines Recall: Glucophage® SR 500 mg, 750mg and 1000mg prolonged-release tablets (Bruno Farmaceutici SpA, Italy) appeared first on Community Pharmacy England.
Recent Comments